Literature DB >> 2499547

Development of resistance to Trypanosoma cruzi in mice depends on a viable population of L3T4+ (CD4+) T lymphocytes.

F G Araujo1.   

Abstract

Mice injected with monoclonal antibody to the L3T4+ (CD4+) cell membrane surface glycoprotein of T lymphocytes and immunized with antigens of Trypanosoma cruzi had reduced antibody and cell-mediated immune responses to the organism. Mortality in these mice was 100% following challenge with 1.5 x 10(5) trypanosomes, whereas controls had a 50% survival rate, indicating that T-cell activation and viable L3T4+ (CD4+) T lymphocytes are essential for the development of resistance.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2499547      PMCID: PMC313867          DOI: 10.1128/iai.57.7.2246-2248.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

1.  Protective immunisation of mice using cell surface glycoprotein from Trypanosoma cruzi.

Authors:  M T Scott; D Snary
Journal:  Nature       Date:  1979-11-01       Impact factor: 49.962

2.  Autoimmune phenomena in chronic chagasic cardiopathy.

Authors:  L Hudson
Journal:  Parasitol Today       Date:  1985-07

3.  L3T4+ T cells able to mediate parasite-specific delayed-type hypersensitivity play a role in the pathology of experimental Chagas' disease.

Authors:  M Hontebeyrie-Joskowicz; G Said; G Milon; G Marchal; H Eisen
Journal:  Eur J Immunol       Date:  1987-07       Impact factor: 5.532

4.  Analysis of Trypanosoma cruzi antigens bound by specific antibodies and by antibodies to related trypanosomatids.

Authors:  F G Araujo
Journal:  Infect Immun       Date:  1986-07       Impact factor: 3.441

5.  Trypanosoma cruzi: effects of anti-thymocyte serum in mice and neonatal thymectomy in rats.

Authors:  E L Roberson; W L Hanson
Journal:  Exp Parasitol       Date:  1973-10       Impact factor: 2.011

Review 6.  A functional dichotomy in CD4+ T lymphocytes.

Authors:  K Bottomly
Journal:  Immunol Today       Date:  1988-09

7.  Use of antigen preparations of the amastigote stage of Trypanosoma cruzi in the serology of Chagas' disease.

Authors:  F G Araujo; D Guptill
Journal:  Am J Trop Med Hyg       Date:  1984-05       Impact factor: 2.345

8.  In vivo T cell depletion regulates resistance and morbidity in murine schistosomiasis.

Authors:  S M Phillips; G P Linette; B L Doughty; J E Byram; F Von Lichtenberg
Journal:  J Immunol       Date:  1987-08-01       Impact factor: 5.422

9.  Suppression of polyclonal antibody production in Trypanosoma cruzi-infected mice by treatment with anti-L3T4 antibodies.

Authors:  P Minoprio; H Eisen; M Joskowicz; P Pereira; A Coutinho
Journal:  J Immunol       Date:  1987-07-15       Impact factor: 5.422

10.  Cellular immunity to Trypanosoma cruzi is mediated by helper T cells (CD4+).

Authors:  A Ben Younès-Chennoufi; G Said; H Eisen; A Durand; M Hontebeyrie-Joskowicz
Journal:  Trans R Soc Trop Med Hyg       Date:  1988       Impact factor: 2.184

View more
  17 in total

1.  Interleukin-12-mediated resistance to Trypanosoma cruzi is dependent on tumor necrosis factor alpha and gamma interferon.

Authors:  C A Hunter; T Slifer; F Araujo
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  Depletion of L3T4+ (CD4+) T lymphocytes prevents development of resistance to Toxoplasma gondii in mice.

Authors:  F G Araujo
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

3.  Infection with Trypanosoma cruzi selectively upregulates B7-2 molecules on macrophages and enhances their costimulatory activity.

Authors:  S Frosch; D Küntzlin; B Fleischer
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

4.  During Trypanosoma cruzi infection CD1d-restricted NK T cells limit parasitemia and augment the antibody response to a glycophosphoinositol-modified surface protein.

Authors:  Malcolm S Duthie; Monika Wleklinski-Lee; Sherilyn Smith; Toshinori Nakayama; Masaru Taniguchi; Stuart J Kahn
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

5.  Depletion of T-cell subpopulations results in exacerbation of myocarditis and parasitism in experimental Chagas' disease.

Authors:  R L Tarleton; J Sun; L Zhang; M Postan
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

6.  The SA85-1.1 protein of the Trypanosoma cruzi trans-sialidase superfamily is a dominant T-cell antigen.

Authors:  A E Millar; S J Kahn
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

7.  Pure paraflagellar rod protein protects mice against Trypanosoma cruzi infection.

Authors:  R A Wrightsman; M J Miller; J L Saborio; J E Manning
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

8.  Further characterization of protective Trypanosoma cruzi-specific CD4+ T-cell clones: T helper type 1-like phenotype and reactivity with shed trypomastigote antigens.

Authors:  S P Nickell; M Keane; M So
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

9.  Immunization with Trypanosoma cruzi epimastigote antigens incorporated into iscoms protects against lethal challenge in mice.

Authors:  F G Araujo; B Morein
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

10.  Differential susceptibilities of mice genomically deleted of CD4 and CD8 to infections with Trypanosoma cruzi or Trypanosoma brucei.

Authors:  M E Rottenberg; M Bakhiet; T Olsson; K Kristensson; T Mak; H Wigzell; A Orn
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.